GO:0140375 immune receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140375 (immune receptor activity) is a molecular function defined as receiving a signal and transmitting it in a cell to initiate an immune response.
• Immune receptor activity is driven by ligand-induced receptor clustering, electrostatic assembly, and local exclusion of inhibitory phosphatases.
• The SYK tyrosine kinase is a central downstream effector of many immune receptor signaling pathways.
• DAMP-sensing receptors are key initiators of inflammation and are implicated in a wide range of diseases.
• Drug hypersensitivity reactions can be initiated through immune receptor activation mechanisms.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential for dissecting immune receptor function.
Description
GO:0140375, immune receptor activity, is a molecular function that describes the ability of a cell to receive a signal and transmit it intracellularly to initiate an immune response. This activity is fundamental to both innate and adaptive immunity, enabling cells to detect pathogens, damaged self, and other danger signals. The QuickGO definition captures the essence of this function: receiving a signal and transmitting it in a cell to initiate an immune response. Immune receptors are not merely binding proteins; they actively convert extracellular or extracellularly derived cues into intracellular signaling cascades that mobilize immune defenses. Research into immune receptor activity spans immunology, cell biology, and pharmacology, with direct relevance to infectious diseases, autoimmunity, cancer, and drug hypersensitivity. Understanding the molecular mechanisms of immune receptor activity is therefore critical for developing targeted immunotherapies and for interpreting genetic variants that alter immune signaling.
immune receptor activity At A Glance
| GO ID | GO:0140375 |
|---|---|
| GO term | immune receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Receiving a signal and transmitting it in a cell to initiate an immune response. |
| Major function | Signal reception and transduction leading to immune response initiation |
| Related kinases | SYK, and other tyrosine kinases |
| Key mechanisms | Receptor clustering, electrostatic assembly, phosphatase exclusion |
| Disease relevance | Inflammation, autoimmunity, drug hypersensitivity, neurodegeneration |
What Is GO:0140375?
In our own words, GO:0140375 (immune receptor activity) refers to the molecular function of a receptor protein that binds a signal, such as a cytokine, pathogen-associated molecular pattern, or damage-associated molecular pattern, and then triggers an intracellular signaling cascade that leads to an immune response. This function is distinct from general signal transduction because its output is specifically the initiation or modulation of immunity. The activity typically involves receptor clustering, conformational changes, and recruitment of adaptor and effector proteins, ultimately activating transcription factors that drive immune gene expression.
Why Is immune receptor activity Important in Cell Biology?
Immune receptor activity is important because it sits at the interface between environmental or endogenous danger signals and the activation of immune responses. Dysregulation of this activity can lead to chronic inflammation, autoimmune diseases, immunodeficiency, and cancer. For researchers, understanding the precise molecular steps of immune receptor activity provides opportunities to design drugs that either boost or dampen immune signaling, as well as to interpret genetic variants that affect receptor function.
• Initiates innate and adaptive immune responses to pathogens and danger signals.
• Central to the pathogenesis of inflammatory and autoimmune diseases.
• Mediates drug hypersensitivity reactions through specific immune receptor activation.
• Involved in neurodegeneration through lectin-mediated immune receptor pathways.
• Provides targets for therapeutic antibodies and small-molecule inhibitors.
• SYK kinase, a downstream effector, is a validated drug target in immunology and oncology.
• Receptor clustering and electrostatic interactions are emerging as regulatory nodes.
• Enforced phosphatase recruitment can inhibit immune receptor signaling, offering a therapeutic strategy.
Molecular Mechanism of immune receptor activity
Ligand binding and receptor clustering
In simple terms: When a signal molecule binds to an immune receptor, multiple receptors come together in groups to start a strong signal.
The first step in immune receptor activity is the binding of a ligand, such as a cytokine, PAMP, or DAMP, to the extracellular domain of the receptor. This binding often induces receptor clustering, which is a key event for signal transduction. Clustering brings receptor intracellular domains into close proximity, allowing for trans-phosphorylation by associated kinases and the formation of signaling platforms. Clustering is regulated by electrostatic interactions between receptor domains and the membrane, as well as by the local lipid environment.
Electrostatic assembly and phosphatase exclusion
In simple terms: Charged interactions help receptors assemble correctly, and they also push away inhibitory enzymes to keep the signal on.
Electrostatic interactions play a critical role in immune receptor assembly and signaling. Positively charged residues in the receptor intracellular domain can interact with negatively charged lipids, stabilizing the receptor in a signaling-competent conformation. Antibody agonists can trigger immune receptor signaling by locally excluding receptor-type protein tyrosine phosphatases (RPTPs), which normally dampen signals. This exclusion is mediated by the spatial organization of the receptor-ligand complex, creating a zone where kinases can act without opposition.
Kinase activation and downstream signaling
In simple terms: Once receptors are clustered, kinases add phosphate groups to proteins, passing the signal along inside the cell.
Following clustering and phosphatase exclusion, receptor-associated kinases, such as SYK, are activated. SYK is a crucial player in diverse biological functions and is recruited to phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) on receptor adaptors. Activated SYK then phosphorylates downstream targets, leading to the activation of transcription factors like NF-kB and NFAT, which drive immune gene expression. This kinase cascade amplifies the initial signal and determines the specificity of the immune response.
Regulation by phosphatases and inhibitors
In simple terms: Inhibitory enzymes can shut down the signal by removing phosphate groups or by being recruited to the receptor.
Immune receptor activity is tightly regulated by phosphatases, such as CD45 and SHP-1, which can dephosphorylate key signaling intermediates. Enforced recruitment of phosphatases to the receptor can inhibit signaling, as demonstrated by engineered systems that recruit RPTPs to immune receptors. This regulatory mechanism prevents excessive immune activation and maintains self-tolerance. Dysregulation of phosphatase activity can lead to autoimmune diseases or immunodeficiency.
DAMP-sensing and inflammation
In simple terms: Receptors can also detect molecules released by damaged cells, triggering inflammation.
DAMP-sensing receptors are a subset of immune receptors that recognize damage-associated molecular patterns released by stressed or dying cells. These receptors initiate inflammatory responses and are implicated in a wide range of diseases, including sterile inflammation, autoimmunity, and cancer. The signaling pathways downstream of DAMP-sensing receptors often converge on NF-kB and inflammasome activation, leading to the production of pro-inflammatory cytokines.
Key Genes Involved in GO:0140375 immune receptor activity
The following genes encode proteins that are directly involved in immune receptor activity, including receptors, kinases, adaptors, and regulatory phosphatases.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SYK | Tyrosine kinase downstream of ITAM-bearing receptors | Central effector of immune receptor signaling; drug target |
| PTPRC | Receptor-type protein tyrosine phosphatase CD45 | Regulates immune receptor signaling by dephosphorylation |
| PTPN6 | Phosphatase SHP-1 | Negative regulator of immune receptor signaling |
| FCER1G | Fc receptor gamma chain with ITAM | Adaptor for many immune receptors |
| TYROBP | DAP12 adaptor with ITAM | Activates SYK in NK and myeloid cells |
| CLEC7A | Dectin-1, a C-type lectin receptor | DAMP-sensing receptor for fungal ligands |
| TLR4 | Toll-like receptor 4 | Senses LPS and DAMPs; initiates inflammation |
| NLRP3 | Inflammasome sensor | DAMP-sensing receptor that activates caspase-1 |
| IL1R1 | Interleukin-1 receptor | Cytokine receptor initiating immune signaling |
| TNFRSF1A | TNF receptor 1 | Cytokine receptor mediating inflammation |
| IFNAR1 | Interferon-alpha/beta receptor | Antiviral immune receptor |
| CD3E | T-cell receptor complex subunit | Adaptor for TCR signaling |
| MS4A2 | Fc epsilon receptor beta chain | Amplifies IgE receptor signaling |
| LILRB1 | Inhibitory receptor with ITIMs | Recruits phosphatases to dampen signaling |
| CD28 | Costimulatory receptor | Enhances T-cell receptor signaling |
| CTLA4 | Inhibitory receptor | Recruits phosphatases to inhibit T-cell signaling |
| PDCD1 | PD-1 inhibitory receptor | Recruits SHP-2 to inhibit signaling |
How Is immune receptor activity Regulated?
Immune receptor activity is regulated at multiple levels, including ligand availability, receptor clustering, electrostatic interactions with the membrane, and the balance between kinase and phosphatase activities. Phosphatases such as CD45 and SHP-1 are key negative regulators, and their recruitment to the receptor complex can terminate signaling. Additionally, receptor clustering is modulated by the actin cytoskeleton and lipid rafts, which concentrate signaling molecules and exclude inhibitory phosphatases. DAMP-sensing receptors are also regulated by the availability of their ligands, which are released during tissue damage or stress.
immune receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SYK | Autoimmune diseases, leukemia | Kinase-dead knock-in; KO in immune cells |
| PTPRC | Autoimmune diseases, immunodeficiency | Point mutation in phosphatase domain; KO |
| TLR4 | Sepsis, inflammatory diseases | KO; point mutation in ligand-binding domain |
| NLRP3 | Cryopyrin-associated periodic syndromes | Knock-in of disease mutations; KO |
| CLEC7A | Fungal infections, colitis | KO; overexpression of decoy receptor |
Immune receptor activity in inflammation and autoimmune diseases
Dysregulated immune receptor activity is a hallmark of chronic inflammatory and autoimmune diseases. DAMP-sensing receptors, such as TLR4 and NLRP3, recognize endogenous danger signals and initiate inflammatory cascades that contribute to conditions like rheumatoid arthritis, lupus, and inflammatory bowel disease. Genetic variants that alter receptor clustering or phosphatase recruitment can lead to excessive or prolonged immune activation, driving autoimmunity.
Drug hypersensitivity and immune receptor activation
Drug hypersensitivity reactions can be initiated through immune receptor activation. Certain drugs can directly bind to immune receptors or their associated molecules, triggering signaling and leading to adverse reactions. The pathomechanism involves both innate and adaptive immune receptor activities, and understanding these mechanisms is crucial for drug safety.
Neurodegeneration and lectin-mediated immune receptor activity
Lectin receptors, which are part of the immune receptor repertoire, have been implicated in neurodegeneration. These receptors can recognize glycans on damaged proteins and initiate neuroinflammatory responses. A glycobiologist's perspective highlights the role of lectins in diseases such as Alzheimer's and Parkinson's, where chronic immune receptor activation contributes to neuronal damage.
Cancer and immune receptor signaling
In cancer, immune receptor activity can be either protective or pathogenic. Inhibitory receptors like PD-1 and CTLA-4 dampen anti-tumor immunity, and blockade of these receptors is a major therapeutic strategy. Conversely, activating receptors such as CD28 can enhance T-cell responses against tumors. Understanding the balance of immune receptor activities is essential for designing effective immunotherapies.
From immune receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X initiate immune receptor signaling? | Knockout cell line (e.g., CRISPR KO) |
| Does a specific mutation alter receptor activity? | Point-mutation knock-in cell line |
| How does receptor clustering affect signaling? | Tagged knock-in with fluorescent tag |
| Can overexpression drive constitutive immune activation? | Overexpression cell line |
| What are the downstream effectors of receptor X? | Knockout + phosphoproteomics |
| Is receptor X required for immune response in vivo? | Knockout mouse model |
How to Study the immune receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Mapping signaling downstream of receptor activation |
| Super-resolution imaging | Receptor clustering and nanoscale organization | Visualizing immune receptor assembly |
| CRISPR knockout screen | Genes required for receptor signaling | Identifying novel regulators |
| In vitro kinase assay | Kinase activity | Testing inhibitors of SYK |
| Phosphatase assay | Phosphatase activity | Measuring CD45 or SHP-1 function |
| Flow cytometry | Surface receptor expression and activation markers | Phenotyping immune cells |
| RNA-seq | Transcriptional changes | Identifying immune response genes |
| Proximity ligation assay | Protein-protein interactions | Detecting receptor-adaptor complexes |
Phosphoproteomics for mapping signaling pathways
Phosphoproteomics allows comprehensive identification of phosphorylation events downstream of immune receptor activation. By comparing wild-type and knockout cells, researchers can pinpoint specific substrates of kinases like SYK and identify signaling nodes that are altered by receptor activity.
Imaging of receptor clustering and localization
Advanced imaging techniques, such as super-resolution microscopy and total internal reflection fluorescence (TIRF) microscopy, enable visualization of receptor clustering at the plasma membrane. These methods can reveal how electrostatic interactions and ligand binding induce nanoscale organization of immune receptors.
CRISPR screens for identifying regulators of immune receptor activity
Genome-wide CRISPR knockout screens can identify genes that are essential for immune receptor signaling. By using reporter cell lines that express fluorescent proteins under the control of immune-responsive promoters, researchers can isolate regulators of receptor activity and validate them in secondary assays.
Biochemical assays for kinase and phosphatase activity
In vitro kinase assays and phosphatase assays measure the enzymatic activity of key regulators such as SYK and CD45. These assays can be used to test small-molecule inhibitors and to determine the kinetic parameters of immune receptor signaling components.
How CRISPR Can Be Used to Study GO:0140375 immune receptor activity
Knockout
CRISPR knockout of genes encoding immune receptors or their downstream effectors is a powerful approach to determine their necessity in immune signaling. For example, SYK knockout cells fail to activate NF-kB in response to ITAM-bearing receptor stimulation, confirming its central role. Knockout models are also used to validate drug targets and to identify compensatory pathways.
Point Mutation
Point mutations can be introduced to dissect specific residues required for immune receptor activity, such as phosphorylation sites or electrostatic interaction motifs. For instance, mutating tyrosine residues in ITAMs prevents SYK recruitment and signaling. Point-mutation models are valuable for understanding the precise molecular determinants of receptor function.
Knock-in
Knock-in of tagged or reporter versions of immune receptors allows for real-time tracking of receptor expression, localization, and clustering. Fluorescently tagged receptors can be used in live-cell imaging to study dynamic assembly at the plasma membrane. Knock-in of disease-associated mutations can also model human immune disorders.
Overexpression
Overexpression of wild-type or mutant immune receptors can drive constitutive signaling and is useful for studying gain-of-function phenotypes. For example, overexpression of constitutively active SYK mutants leads to uncontrolled immune activation. Overexpression models are also used to screen for inhibitors that block receptor signaling.
How EDITGENE Supports immune receptor activity Research
Researchers studying immune receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, and to dissect the precise molecular mechanisms. This requires robust genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant immune cell types. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for immune receptor activity research.
Frequently Asked Questions About immune receptor activity
What is GO:0140375 immune receptor activity?
GO:0140375 is a molecular function defined as receiving a signal and transmitting it in a cell to initiate an immune response. It encompasses the receptor-mediated events that lead to immune activation.
What genes are involved in immune receptor activity?
Key genes include SYK, PTPRC, TLR4, NLRP3, and many others encoding receptors, kinases, and adaptors that participate in immune signaling.
How does immune receptor clustering work?
Ligand binding induces receptors to cluster at the plasma membrane, bringing their intracellular domains together to facilitate phosphorylation and signaling. Electrostatic interactions and phosphatase exclusion are critical for this process.
What is the role of SYK in immune receptor activity?
SYK is a tyrosine kinase that is recruited to phosphorylated ITAMs on immune receptors and propagates signals downstream, activating transcription factors that drive immune responses.
How are immune receptors regulated?
Immune receptor activity is regulated by phosphatases such as CD45 and SHP-1, which dephosphorylate signaling intermediates, as well as by receptor clustering and electrostatic interactions.
What diseases are associated with abnormal immune receptor activity?
Dysregulated immune receptor activity is linked to chronic inflammation, autoimmune diseases, drug hypersensitivity, neurodegeneration, and cancer.
How can CRISPR be used to study immune receptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect the function of specific genes and mutations in immune receptor signaling pathways.
What methods are used to study immune receptor signaling?
Common methods include phosphoproteomics, super-resolution imaging, CRISPR screens, kinase assays, and flow cytometry.
What are DAMP-sensing receptors?
DAMP-sensing receptors are immune receptors that recognize damage-associated molecular patterns released by stressed or dying cells, initiating inflammatory responses.
How does EDITGENE support immune receptor research?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services to study immune receptor activity.
Conclusion
GO:0140375 immune receptor activity is a fundamental molecular function that underlies the initiation of immune responses. Its mechanisms involve ligand-induced clustering, electrostatic assembly, kinase activation, and phosphatase regulation. Dysregulation of this activity contributes to a wide range of diseases, making it a prime target for therapeutic intervention. CRISPR-based models are indispensable for dissecting the genetic and molecular basis of immune receptor activity, and EDITGENE offers comprehensive services to support this research.
References
- 1. Ma M et al.. 2024. DAMPs and DAMP-sensing receptors in inflammation and diseases.. Immunity 57(4):752-771 PMID: 38599169
- 2. Pichler WJ. 2019. Immune pathomechanism and classification of drug hypersensitivity.. Allergy 74(8):1457-1471 PMID: 30843233
- 3. Lippert AH et al.. 2024. Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.. Immunity 57(2):256-270.e10 PMID: 38354703
- 4. Mócsai A et al.. 2010. The SYK tyrosine kinase: a crucial player in diverse biological functions.. Nat Rev Immunol 10(6):387-402 PMID: 20467426
- 5. Fernandes RA et al.. 2020. Immune receptor inhibition through enforced phosphatase recruitment.. Nature 586(7831):779-784 PMID: 33087934
- 6. Connolly A et al.. 2019. Electrostatic interactions: From immune receptor assembly to signaling.. Immunol Rev 291(1):26-43 PMID: 31402503
- 7. Li M et al.. 2021. Innate immune receptor clustering and its role in immune regulation.. J Cell Sci 134(4) PMID: 33597156
- 8. Olejnik B et al.. 2025. Lectins and neurodegeneration: A glycobiologist's perspective.. Adv Clin Exp Med 34(5):673-679 PMID: 40405515
